CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 23 enrolled
Drug / intervention
Leva Incontinence System For Pelvic Floor Muscle strengtheningdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03536923
NCT03536923N/ACompleted

Use of the Leva Incontinence System in Treating Bladder Incontinence.

Renovia, Inc.·interventional·Posted May 25, 2018·Updated Dec 12, 2018

In Brief

A clinical study evaluating Leva Incontinence System For Pelvic Floor Muscle strengthening for Stress Urinary Incontinence. Completed, enrolled 23 participants across 1 site.

Detailed Summary

This open-label proof-of-concept study is designed to evaluate the impact of the leva digital incontinence system on the treatment of stress and mixed urinary incontinence in women over a six week period. Subjects will participate in a 2.5 minute exercise program twice daily (performed at a clinic with therapist assistance 5x weekly, and at home once daily on weekdays and twice daily on weekends. Validated surveys (UDI-6, IIQ-7 and PGI-I) will be used to evaluate symptom relief. A battery of pelvic floor muscle exercises will be performed weekly to evaluate progress in muscle strengthening.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedMay 25, 2018
Enrollment StartApr 10, 2017
Primary CompletionAug 12, 2017
Study CompletionOct 20, 2017
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 8.1 years ago

Interventions

Leva Incontinence System For Pelvic Floor Muscle strengtheningdevice

The leva device is placed vaginally for 2.5 minutes twice daily, and pelvic floor muscle exercises are performed based on guidance from data sent from the device to their mobile phone.